Likewise, blocking the CXCL12/CXCR4 pathway during engraftment of 4T1 mammary carcinoma cells in BALB/c mice yielded similar results (1 in 496 vehicle vs. 1 in 2,466 AMD3100) (Fig.6B). The gene discussed is CXCL12; the disease is breast carcinoma.